Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology,
Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Illumina
| Company | Illumina |
|---|---|
| Name of system | NovaSeq 6000Dx |
| City, State | San Diego, CA |
| Phone | 858-202-4500 |
| Website | |
| System application/FDA cleared or approved | in vitro diagnostic and research use/yes |
| Country where designed/Manufactured | U.S./U.S. |
| First year sold in U.S./First year installed in U.S. | 2022/2022 |
| System sold internationally | yes (worldwide) |
| Dimensions of sequencer (H × W × D)/Footprint of sequencer | 65.2 × 31.5 × 37.2 in./8.2 sq. ft. |
| Accessory equipment supplied with sequencer at no cost | Illumina DRAGEN server for NovaSeq 6000Dx |
| Type of computer supplied with sequencer | computer for analysis and operations combined |
| Analysis options provided with sequencer | onboard, cluster based, cloud based |
| Where library preparation is performed | wet bench |
| Bioinformatics tools provided with sequencer | DRAGEN Bio-IT platform, Illumina Run Manager, BaseSpace Sequence Hub |
| Sequencer supplied with UPS (uninterruptible power supply) | yes (no extra charge) |
| Electrical connection required for sequencer | 200–240 VAC at 50/60 Hz, 16 A, single phase, 2500 W |
| List price of entire sequencer and necessary components | $850,000 |
| Purchase options | purchase, lease, reagent rental |
| Warranties offered | first year included with purchase; extended warranty available |
| Training included/Total time for basic training per operator | yes/2 days |
| Training location/Follow-up training available | at customer site/yes (extra charge) |
| Maximum No. of samples amplified in a single amplification event | 384 samples (>384 samples with custom barcodes) |
| Read length/Percent bases >Q30 | 1 × 35–2 × 250 bp/90% (1 × 35 bp, 2 × 50 bp); 85% (2 × 200 bp, 2 × 150 bp); 75% (2 × 250 bp) |
| Paired-end capability/Tag lengths/Spans | yes/up to 2 × 250 bp/up to 550 bp |
| Fragment/Tag lengths/Spans | yes/up to 2 × 250 bp/up to 550 bp |
| Mate pair/Tag lengths/Spans | yes/up to 2 × 250 bp/2–12 kb |
| Single end/Tag lengths/Spans | yes/up to 1 × 300 bp/up to 350 bp |
| RNA sequencing/Tag lengths/Spans | yes/up to 2 × 250 bp/up to 500 bp |
| ChIP sequencing/Tag lengths/Spans | yes/up to 2 × 250 bp/up to 550 bp |
| Bisulfite sequencing/Tag lengths/Spans | yes/up to 2 × 250 bp/up to 550 bp |
| Maximum No. of reads or fragments sequenced per single-end run | up to 20 billion |
| Maximum No. of reads or fragments sequenced per paired-end run | up to 40 billion |
| Total No. of nucleotides (bases) sequenced per run | up to 6,000 Gb per run, 3,000 Gb per flow cell |
| Wet lab bench time for sequencing preparation | 10 minutes |
| Sequencing run time | <45 hours |
| Total time for generating standard gDNA library | <3.5 hours (with Illumina DNA Prep) |
| • Paired end | <3.5 hours (with Illumina DNA Prep) |
| • Fragment | <7 hours (with AmpliSeq for Illumina); <6.5 hours (with Illumina DNA Prep with Enrichment) |
| • Mate pair | — |
| • Single end | <1 day (with TruSeq Small RNA) |
| • RNA sequencing | <9 hours |
| • Bisulfite sequencing | — |
| • Hands-on time for paired end | <1.5 hours (with Illumina DNA Prep) |
| • Hands-on time for fragment | <1.5 hours (with AmpliSeq for Illumina); <2 hours (with Illumina DNA Prep with Enrichment) |
| • Hands-on time for mate pair | — |
| • Hands-on time for single end | <4 hours (with TruSeq Small RNA) |
| • Hands-on time for RNA sequencing | <3 hours |
| • Hands-on time for ChIP sequencing | — |
| • Hands-on time for bisulfite sequencing | — |
| Library preparation integrated in system as standard offering | no |
| Cost of sequencing reagents per run | $2,490–$17,324 |
| Reagent tracking method | RFID |
| • Type of reagent information tracked | serial No., expiration date, lot and part Nos., No. of cycles |
| Shipping conditions for amplification/sequencing reagents | —/dry ice, gel pack, ambient (variable based on product) |
| Storage conditions for amplification/sequencing reagents | —/cluster, SBS cartridges: -15°– -25°C; flow cell: 2°– 8°C; buffer cartridge: 15°– 30°C |
| Shelf life of amplification/sequencing reagents | —/up to 24 months |
| System requires a control sample on sequencing run | optional |
| • Company offers a sequencing control | yes (additional charge) |
| Sequencing system control software and devices to start run/for data analysis | —/BaseSpace Sequence Hub, DRAGEN |
| Complete walkaway automation for amplification, sequencing, and variant calling | yes |
| Remote system monitoring | yes |
| Total time required for setup of amplification, sequencing, and variant calling steps | 5–30 minutes |
| Maximum No. of libraries sequenced in a single run | 384 samples (>384 samples with custom barcodes) |
| System includes secondary data-analysis software developed by company | yes (Illumina Run Manager) |
| System includes post-sequencing data-analysis software | yes (Illumina Run Manager) |
| Mutations detectable via data-analysis software | substitutions, indels, copy number changes |
| System can generate a variant report | yes |
| Types of maintenance plans available/mean time between failures | gold, silver, bronze/— |
| No. of field application scientists and engineers based in U.S. | >500 |
| • Weekly maintenance required | none (maintenance wash every 2 weeks) |
| • Monthly maintenance required | — |
| • Pre-run maintenance required | — |
| Distinguishing features of NGS system (supplied by company) | more samples and deeper sequencing from diagnostic testing to clinical research; flexible RUO and IVD modes with scalable sequencing power; accurate, efficient data analysis; high-quality data with a paired, dedicated DRAGEN server; reduce time to answer; reimagined user interface with a simple workflow |